Catalent
CTLT
$55.80
Share price
-0.29%
Change (1 day)
32.60%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) Fails to deliver data
Key failure to deliver metrics for Catalent:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.22 M
- Last 3 months FTD volume: $24 M
- Last year FTD volume: $64.42 M
Failures to deliver for Catalent (CTLT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Catalent (CTLT) - since 2014
Volume in USD (price x number of shares), data since 2014Catalent (CTLT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $24 M | -58.62% |
| 2023 | $58 M | 104.08% |
| 2022 | $28.42 M | -52.48% |
| 2021 | $59.82 M | -67.12% |
| 2020 | $0.18 B | 1827.57% |
| 2019 | $9.43 M | 27.98% |
| 2018 | $7.37 M | 45.63% |
| 2017 | $5.06 M | -84.93% |
| 2016 | $33.61 M | 108.12% |
| 2015 | $16.15 M | 39.69% |
| 2014 | $11.56 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.2 M | $2.29 M | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $0.86 M | $8.12 M | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | N/A | $0.94 M | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | N/A | $55.41 M | 🇺🇸 USA |